Dereplication-guided isolation of a new indole alkaloid triglycoside from the hooks of Uncaria rhynchophylla by LC with ion trap time-of-flight MS.
Jian-Gang ZhangXiao-Yan HuangYun-Bao MaXue-Mei ZhangJi-Jun ChenChang-An GengPublished in: Journal of separation science (2018)
Uncaria rhynchophylla (Gou-Teng) as the monarch herb of many formulae (Fufang), e.g. "Tian-Ma-Gou-Teng-Yin," "Ling-Jiao-Gou-Teng-Yin," and "Yi-Gan-San", is a famous traditional Chinese medicine documented in the Chinese pharmacopoeia for mental and cardiovascular diseases. In the traditional Chinese medicine system, only the hook-bearing stems are used as the crude materials for Gou-Teng, and the hooks are always considered more effective than the stems. Focusing on the mono-herb and its active constituents from combinatorial formulae is the core idea of reductionism of traditional Chinese medicine theory. Detailed liquid chromatography with mass spectrometry analysis on the hooks of U. rhynchophylla was performed to profile the chemical constituents based on tandem mass spectrometry fragmentation and UV absorption. Under the guidance of liquid chromatography with ion trap/time-of-flight mass spectrometry, one new indole alkaloid triglycoside (1), together with five known compounds 2-6 as the main constituents, were isolated from the hooks of U. rhynchophylla by various column chromatography methods. Compound 1 showed moderate activity on MT1 and MT2 melatonin receptors with agonistic rates of 79.6 and 46.3% at the concentration of 1 mM. This dereplication strategy can be equally applicable to rapidly disclose the active constituents of other Chinese herbs through targeted purification.
Keyphrases
- liquid chromatography
- mass spectrometry
- tandem mass spectrometry
- ultra high performance liquid chromatography
- high resolution mass spectrometry
- simultaneous determination
- high performance liquid chromatography
- gas chromatography
- solid phase extraction
- essential oil
- cardiovascular disease
- high resolution
- capillary electrophoresis
- mental health
- cancer therapy
- multiple sclerosis
- cardiovascular events
- coronary artery disease
- drug delivery
- metabolic syndrome